Research Article | Open Access
Masafumi Takahashi, Takatoshi Ishiko, Hidenobu Kamohara, Hideaki Hidaka, Osamu Ikeda, Michio Ogawa, Hideo Baba, "Curcumin (1,7-bis(4-hydroxy-3-methoxyphenyl)-1, 6-heptadiene-3,5-dione) Blocks the Chemotaxis of Neutrophils by Inhibiting Signal Transduction through IL-8 Receptors", Mediators of Inflammation, vol. 2007, Article ID 010767, 11 pages, 2007. https://doi.org/10.1155/2007/10767
Curcumin (1,7-bis(4-hydroxy-3-methoxyphenyl)-1, 6-heptadiene-3,5-dione) Blocks the Chemotaxis of Neutrophils by Inhibiting Signal Transduction through IL-8 Receptors
We investigated the impact of curcumin on neutrophils. Chemotactic activity via human recombinant IL-8 (hrIL-8) was significantly inhibited by curcumin. Curcumin reduced calcium ion flow induced by internalization of the IL-8 receptor. We analyzed flow cytometry to evaluate the status of the IL-8 receptor after curcumin treatment. The change in the distribution of receptors intracellularly and on the cell surface suggested that curcumin may affect the receptor trafficking pathway intracellulary. Rab11 is a low molecular weight G protein associated with the CXCR recycling pathway. Following curcumin treatment, immunoprecipitation studies showed that the IL-8 receptor was associated with larger amounts of active Rab11 than that in control cells. These data suggest that curcumin induces the stacking of the Rab11 vesicle complex with CXCR1 and CXCR2 in the endocytic pathway. The mechanism for antiinflammatory response by curcumin may involve unique regulation of the Rab11 trafficking molecule in recycling of IL-8 receptors.
- O. P. Sharma, “Antioxidant activity of curcumin and related compounds,” Biochemical Pharmacology, vol. 25, no. 15, pp. 1811–1812, 1976.
- K. K. Soudamini and R. Kuttan, “Inhibition of chemical carcinogenesis by curcumin,” Journal of Ethnopharmacology, vol. 27, no. 1-2, pp. 227–233, 1989.
- J. C. Baumann, “Effect of chelidonium, curcuma, absinth and Carduus marianus on the bile and pancreatic secretion in liver diseases,” Medizinische Monatsschrift, vol. 29, no. 4, pp. 173–180, 1975.
- Y. X. Xu, K. R. Pindolia, N. Janakiraman, C. J. Noth, R. A. Chapman, and S. C. Gautam, “Curcumin, a compound with anti-inflammatory and anti oxidant properties, down-regulates chemokine expression in bone marrow stromal cells,” Experimental Hematology, vol. 25, no. 5, pp. 413–422, 1997.
- J. Miquel, A. Bernd, J. Sempere, J. Díaz-Alperi, and A. Ramírez, “The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review,” Archives of Gerontology and Geriatrics, vol. 34, no. 1, pp. 37–46, 2002.
- M.-S. Woo, S.-H. Jung, S.-Y. Kim et al., “Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells,” Biochemical and Biophysical Research Communications, vol. 335, no. 4, pp. 1017–1025, 2005.
- Y.-R. Chen and T.-H. Tan, “Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin,” Oncogene, vol. 17, no. 2, pp. 173–178, 1998.
- H. Hidaka, T. Ishiko, T. Furuhashi et al., “Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface: impact on human pancreatic carcinoma cell growth by autocrine regulation,” Cancer, vol. 95, no. 6, pp. 1206–1214, 2002.
- C. Jobin, C. A. Bradham, M. P. Russo et al., “Curcumin blocks cytokine-mediated NF-B activation and proinflammatory gene expression by inhibiting inhibitory factor I-B kinase activity,” Journal of Immunology, vol. 163, no. 6, pp. 3474–3483, 1999.
- S. Singh and B. B. Aggarwal, “Activation of transcription factor NF-B is suppressed by curcumin (diferulolylmethane),” Journal of Biological Chemistry, vol. 270, no. 42, pp. 24995–25000, 1995.
- B. Y. Kang, S. W. Chung, W.-J. Chung, S.-Y. Im, S. Y. Hwang, and T. S. Kim, “Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin,” European Journal of Pharmacology, vol. 384, no. 2-3, pp. 191–195, 1999.
- B. Gupta and B. Ghosh, “Curcuma longa inhibits TNF- induced expression of adhesion molecules on human umbilical vein endothelial cells,” International Journal of Immunopharmacology, vol. 21, no. 11, pp. 745–757, 1999.
- P. M. Murphy and H. L. Tiffany, “Cloning of complementary DNA encoding a functional human interleukin-8 receptor,” Science, vol. 253, no. 5025, pp. 1280–1283, 1991.
- J. Lee, R. Horuk, G. C. Rice, G. L. Bennett, T. Camerato, and W. I. Wood, “Characterization of two high affinity human interleukin-8 receptors,” Journal of Biological Chemistry, vol. 267, no. 23, pp. 16283–16287, 1992.
- K. Asagoe, K. Yamamoto, A. Takahashi et al., “Down-regulation of CXCR2 expression on human polymorphonuclear leukocytes by TNF-,” Journal of Immunology, vol. 160, no. 9, pp. 4518–4525, 1998.
- M. Baggiolini, B. Dewald, and B. Moser, “Human chemokines: an update,” Annual Review of Immunology, vol. 15, pp. 675–705, 1997.
- R. Feniger-Barish, M. Ran, A. Zaslaver, and A. Ben-Baruch, “Differential modes of regulation of CXC chemokine-induced internalization and recycling of human CXCR1 and CXCR2,” Cytokine, vol. 11, no. 12, pp. 996–1009, 1999.
- J. J. Rose, J. F. Foley, P. M. Murphy, and S. Venkatesan, “On the mechanism and significance of ligand-induced internalization of human neutrophil chemokine receptors CXCR1 and CXCR2,” Journal of Biological Chemistry, vol. 279, no. 23, pp. 24372–24386, 2004.
- J. Barlic, M. H. Khandaker, E. Mahon et al., “-arrestins regulate interleukin-8-induced CXCR1 internalization,” Journal of Biological Chemistry, vol. 274, no. 23, pp. 16287–16294, 1999.
- A. Chuntharapai and K. J. Kim, “Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor,” Journal of Immunology, vol. 155, no. 5, pp. 2587–2594, 1995.
- R. M. Richardson, B. C. Pridgen, B. Haribabu, H. Ali, and R. Snyderman, “Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2. Evidence for time-dependent signal generation,” Journal of Biological Chemistry, vol. 273, no. 37, pp. 23830–23836, 1998.
- W. Yang, D. Wang, and A. Richmond, “Role of clathrin-mediated endocytosis in CXCR2 sequestration, resensitization, and signal transduction,” Journal of Biological Chemistry, vol. 274, no. 16, pp. 11328–11333, 1999.
- M. E. W. Hammond, G. R. Lapointe, P. H. Feucht et al., “IL-8 induces neutrophil chemotaxis predominantly via type I IL-8 receptors,” Journal of Immunology, vol. 155, no. 3, pp. 1428–1433, 1995.
- M. Bhattacharya, A. V. Babwah, and S. S. G. Ferguson, “Small GTP-binding protein-coupled receptors,” Biochemical Society Transactions, vol. 32, part 6, pp. 1040–1044, 2004.
- J. S. Rodman and A. Wandinger-Ness, “Rab GTPases coordinate endocytosis,” Journal of Cell Science, vol. 113, no. 2, pp. 183–192, 2000.
- M. Wilcke, L. Johannes, T. Galli, V. Mayau, B. Goud, and J. Salamero, “Rab11 regulates the compartmentalization of early endosomes required for efficient transport from early endosomes to the trans-golgi network,” Journal of Cell Biology, vol. 151, no. 6, pp. 1207–1220, 2000.
- G.-H. Fan, L. A. Lapierre, J. R. Goldenring, J. Sai, and A. Richmond, “Rab11-family interacting protein 2 and myosin Vb are required for CXCR2 recycling and receptor-mediated chemotaxis,” Molecular Biology of the Cell, vol. 15, no. 5, pp. 2456–2469, 2004.
- G.-H. Fan, L. A. Lapierre, J. R. Goldenring, and A. Richmond, “Differential regulation of CXCR2 trafficking by Rab GTPases,” Blood, vol. 101, no. 6, pp. 2115–2124, 2003.
- W. Falk, R. H. Goodwin Jr., and E. J. Leonard, “A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration,” Journal of Immunological Methods, vol. 33, no. 3, pp. 239–247, 1980.
- S. Ali, A. C. V. Palmer, S. J. Fritchley, Y. Maley, and J. A. Kirby, “Multimerization of monocyte chemoattractant protein-1 is not required for glycosaminoglycan-dependent transendothelial chemotaxis,” Biochemical Journal, vol. 358, no. 3, pp. 737–745, 2001.
- B. J. Mounho, D. R. Davila, and S. W. Burchiel, “Characterization of intracellular calcium responses produced by polycyclic aromatic hydrocarbons in surface marker-defined human peripheral blood mononuclear cells,” Toxicology and Applied Pharmacology, vol. 145, no. 2, pp. 323–330, 1997.
- S. W. Burchiel, B. S. Edwards, F. W. Kuckuck et al., “Analysis of free intracellular calcium by flow cytometry: multiparameter and pharmacologic applications,” Methods, vol. 21, no. 3, pp. 221–230, 2000.
- L. J. Picker, M. K. Singh, Z. Zdraveski et al., “Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry,” Blood, vol. 86, no. 4, pp. 1408–1419, 1995.
- S. Suzuki, M. Kobayashi, K. Chiba et al., “Autocrine production of epithelial cell-derived neutrophil attractant-78 induced by granulocyte colony-stimulating factor in neutrophils,” Blood, vol. 99, no. 5, pp. 1863–1865, 2002.
- I. Sabroe, T. J. Williams, C. A. Hébert, and P. D. Collins, “Chemoattractant cross-desensitization of the human neutrophil IL-8 receptor involves receptor internalization and differential receptor subtype regulation,” Journal of Immunology, vol. 158, no. 3, pp. 1361–1369, 1997.
- R. M. Richardson, R. J. Marjoram, L. S. Barak, and R. Snyderman, “Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation,” Journal of Immunology, vol. 170, no. 6, pp. 2904–2911, 2003.
- D. Wu, G. J. LaRosa, and M. I. Simon, “G protein-coupled signal transduction pathways for interleukin-8,” Science, vol. 261, no. 5117, pp. 101–103, 1993.
- R. H. Moore, E. E. Millman, E. Alpizar-Foster, W. Dai, and B. J. Knoll, “Rab11 regulates the recycling and lysosome targeting of -adrenergic receptors,” Journal of Cell Science, vol. 117, no. 15, pp. 3107–3117, 2004.
- L. A. Volpicelli, J. J. Lah, G. Fang, J. R. Goldenring, and A. I. Levey, “Rab11a and myosin Vb regulate recycling of the M4 muscarinic acetylcholine receptor,” Journal of Neuroscience, vol. 22, no. 22, pp. 9776–9784, 2002.
- S. Reddy and B. B. Aggarwal, “Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase,” FEBS Letters, vol. 341, no. 1, pp. 19–22, 1994.
- S. Anuchapreeda, P. Leechanachai, M. M. Smith, S. V. Ambudkar, and P.-N. Limtrakul, “Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells,” Biochemical Pharmacology, vol. 64, no. 4, pp. 573–582, 2002.
- H. Ligeret, S. Barthelemy, R. Zini, J.-P. Tillement, S. Labidalle, and D. Morin, “Effects of curcumin and curcumin derivatives on mitochondrial permeability transition pore,” Free Radical Biology and Medicine, vol. 36, no. 7, pp. 919–929, 2004.
- T. Atsumi, Y. Murakami, K. Shibuya, K. Tonosaki, and S. Fujisawa, “Induction of cytotoxicity and apoptosis and inhibition of cyclooxygenase-2 gene expression, by curcumin and its analog, -diisoeugenol,” Anticancer Research, vol. 25, no. 6B, pp. 4029–4036, 2005.
- C. A. Dinarello, J. A. Gelfand, and S. M. Wolff, “Anticytokine strategies in the treatment of the systemic inflammatory response syndrome,” Journal of the American Medical Association, vol. 269, no. 14, pp. 1829–1835, 1993.
Copyright © 2007 Masafumi Takahashi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.